Nouscom appoints new Chief Operating Officer and strengthens the Board of Directors with industry veterans and scientifics experts
Basel, Switzerland – 26 September 2016 Nouscom, an oncology company developing patient specific cancer vaccines based on a clinically validated genetic vaccine platform, today announced the [...]
